BWAY > BrainsWay Received FDA Clearance for Smoking-Cessation Aid 7:13 am ET August 24, 2020 (Dow Jones) Print By Dave Sebastian
BrainsWay Ltd. said the Food and Drug Administration has granted a clearance for its deep transcranial magnetic simulation system as an aid in short-term smoking cessation in adults.
The company on Monday said it plans to do a controlled U.S. market release in early 2021 for the system.
BrainsWay said it tested the system on 262 eligible subjects, assessing their four-week continuous quit rate.